(Q59230712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

opportunistic infection

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kathleen A. Shutt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

David L Paterson

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Shahid Husain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Eun J Kwak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Fernanda P Silveira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Magdaline Ndirangu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Jerry Tran

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ron Shapiro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ngoc Thai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kareem Abu-Elmagd

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kenneth R McCurry

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Amadeo Marcos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

language of work or name

English

0 references

publication date

13 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

204-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

Tolerogenic immunosuppression for organ transplantation

23 December 2019

cites work

1 reference

The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora

21 January 2018

1 reference

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

21 January 2018

1 reference

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

21 January 2018

1 reference

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

21 January 2018

1 reference

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy

21 January 2018

1 reference

Reversal of acute cellular rejection after renal transplantation with Campath-1H.

21 January 2018

1 reference

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

21 January 2018

1 reference

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation

21 January 2018

1 reference

Campath-1H in intestinal and multivisceral transplantation: preliminary data

21 January 2018

1 reference

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath

21 January 2018

1 reference

Campath-1H in renal transplantation: The University of Wisconsin experience.

21 January 2018

1 reference

Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results

21 January 2018

1 reference

The impact of Campath 1H induction in adult liver allotransplantation

21 January 2018

1 reference

Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation

21 January 2018

1 reference

Lymphoplasmacytic hyperplasia (possibly pre-PTLD) has varied expression and appearance in intestinal transplant recipients receiving Campath immunosuppression

21 January 2018

1 reference

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

21 January 2018

1 reference

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

21 January 2018

1 reference

Fungal infections in transplant recipients receiving alemtuzumab

21 January 2018

1 reference

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

21 January 2018

1 reference

21 January 2018

1 reference

Immunosuppression: evolution in practice and trends, 1994-2004.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/510388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173218%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference